<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62146">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02004236</url>
  </required_header>
  <id_info>
    <org_study_id>Autism and tRNS</org_study_id>
    <nct_id>NCT02004236</nct_id>
  </id_info>
  <brief_title>tRNS Over Fronto-temporal Cortex Improves Verbal Fluency and Empathy in Autism Children</brief_title>
  <acronym>tRNS25112013</acronym>
  <official_title>Transcranial Random Noise Noninvasive Brain Stimulation Applied to the Fronto-temporal Cortex Improves Verbal Fluency and Emphaty in Children With Autistic Spectrum Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spanish Foundation for Neurometrics Development</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spanish Foundation for Neurometrics Development</source>
  <oversight_info>
    <authority>National Health Services: Spain</authority>
    <authority>Community Health Services: Valencia</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional, prospective, randomized, double-blind, placebo-controlled and parallel
      assignment study, in which patients with Autism Spectrum Disorder (ASD) are two types of
      intervention by transcranial random noise stimulation (tRNS), to improve verbal fluency and
      empathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interventional, prospective, randomized, double-blind, placebo-controlled and parallel
      assignment study, in which patients receive three types of intervention tRNS: one group
      received 35 sessions focused on the fronto-temporal cortex, another group received 35
      sessions focused on the temporal fusiform cortex and last placebo group was operated with 35
      sessions tRNS. After brain noninvasive stimulation sessions, a blind analysis of the
      improvement in verbal fluency and empathy in patients with autism spectrum disorder is made.
      For each patient included a follow up period of three months will be established.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>Phase 0</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Verbal fluency</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>improve in verbal fluency in autism spectrum disorder children between 5 and 12 years</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sociability</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Evaluate emphaty with CARS scale in autism spectrum disorder children between 5 and 12 years after tRNS sessions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>QEEG changes in children with ASD</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Evaluate QEEG (brainwave changes in frequecy bands and amplitude) after tRNS intervention in ASD children between 5 and 12 years old</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ERP changes in ASD children after tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Measure changes in ERP waves after tRNS intervention during 3 months in ASD children between 5 and 12 years old</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Autism</condition>
  <condition>ASD</condition>
  <arm_group>
    <arm_group_label>tRNS Fronto-temporal cortex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tRNS over fusiform temporal cortex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tRNS with sham</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This group receive 35 sessions with sham</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tRNS Fronto-temporal cortex</intervention_name>
    <description>This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
    <arm_group_label>tRNS Fronto-temporal cortex</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tRNS over fusiform temporal cortex</intervention_name>
    <description>This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
    <arm_group_label>tRNS over fusiform temporal cortex</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tRNS with sham</intervention_name>
    <description>the subjects receive 35 session with sham</description>
    <arm_group_label>tRNS with sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 5 and 12 years.

          -  Meet DSM-IV criteria for autism spectrum disorder.

          -  Patients who have been diagnosed at least 2 years before inclusion in the study.

        Exclusion Criteria:

          -  Acute visual or hearing loss.

          -  Traumatic brain injury.

          -  Other neurological disorders: migraine, epilepsy, tuberous sclerosis ...

          -  Trauma at birth.

          -  Mental retardation.

          -  Pregnancy.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Moises Aguilar Domingo, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Spanish Foundation for Neurometrics Development</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fernando Vargas-Torcal, PhD</last_name>
    <phone>966 61 69 00</phone>
    <email>vargas_fer@gva.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>General Elche Hospital</name>
      <address>
        <city>Elche</city>
        <state>Alicante</state>
        <zip>03203</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Fernando Vargas-Torcal, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.neurometrics.es</url>
    <description>Neurometrics</description>
  </link>
  <link>
    <url>http://www.dep20.san.gva.es/</url>
    <description>General Elche Hospital</description>
  </link>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>December 2, 2013</lastchanged_date>
  <firstreceived_date>November 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tRNS</keyword>
  <keyword>QEEG</keyword>
  <keyword>ERP</keyword>
  <keyword>ASD</keyword>
  <keyword>Autism</keyword>
  <keyword>verbal fluency</keyword>
  <keyword>empathy</keyword>
  <keyword>noninvasive brain stimulation</keyword>
  <keyword>tDCS</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Autistic Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
